If you liked this article you might like

Biogen CEO Resigns After Six Years of Boom-and-Bust Leadership

Biogen CEO Resigns After Six Years of Boom-and-Bust Leadership

Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact

Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact

Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial

Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial

XBiotech Colon Cancer Drug Data Deemed Unreliable by European Group

XBiotech Colon Cancer Drug Data Deemed Unreliable by European Group